Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART: Crisaborole vs Betamethasone Valerate Safety Biomarkers in AD
NCT04194814Phase 2Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Nov 2020
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of AN2728 ointment vehicle in atopic dermatitis (AD) (2 arms), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoint: Change in Epidermal Thickness at Day 57. Started Nov 2020; status: completed.
02
Drugs
AN2728 ointment vehicle
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04194814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04194814.